Workflow
NewAmsterdam Pharma Company N.V. (NAMS) Reports Q3 Loss, Lags Revenue Estimates
NewAmsterdam Pharma pany N.V.NewAmsterdam Pharma pany N.V.(US:NAMS) ZACKS·2025-11-05 23:15

NewAmsterdam Pharma Company N.V. (NAMS) came out with a quarterly loss of 0.41pershareversustheZacksConsensusEstimateofalossof0.41 per share versus the Zacks Consensus Estimate of a loss of 0.38. This compares to a loss of 0.18pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof−7.890.18 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -7.89%. A quarter ago, it was expected that this company would post a loss of 0.52 per share when it actually produced a loss of $0.15, delivering a surprise of +71.15%.Over the last four quarters, the ...